CRVS
Corvus Pharmaceuticals, Inc. · Healthcare
Insiders bought $334K net in the last 90 days ·0 sellers, 2 buyers· latest Form 4 filed Jun 15, 2026
Insider Buying
$334K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Jun 15, 2026
Moore David Scott
Corvus Pharmaceuticals, Inc. (CRVS) has 3 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 15, 2026.
Inside the rolling window, 2 insiders at Corvus Pharmaceuticals, Inc. reported 2 open-market purchases totaling $334K and no open-market sales. Insiders have net bought $334K over the trailing 6 months. The most recent open-market filing is a purchase of 21,700 shares by Director Moore David Scott, dated Jun 11, 2026, worth $250K.
- Industry:Biotechnology
- CEO:Richard A. Miller
- Employees:37
- HQ:South San Francisco, CA, US
- IPO:2016-03-23
| Source | |||||||
|---|---|---|---|---|---|---|---|
Moore David ScottFirst filing | Director | Purchase | 21,700 | $250K | Jun 15 | +8.7% | SEC ↗ |
MILLER RICHARD A MDFirst filing | President and CEO | Purchase | 6,932 | $83K | May 20 | +6.2% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does CRVS have?
Corvus Pharmaceuticals, Inc. (CRVS) has 3 SEC Form 4 filings (16 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Jun 15, 2026.
When was the most recent SEC Form 4 filing for CRVS?
The most recent Form 4 filing for CRVS on Tracefour is dated Jun 15, 2026.
What is the net insider flow at CRVS over the last 6 months?
Over the trailing 180 days, insiders at CRVS have net bought $334K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CRVS in the current window?
Inside the rolling window, insiders at CRVS bought $334K and sold $0 based on SEC Form 4 filings.
Can I get alerts for CRVS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Corvus Pharmaceuticals, Inc. (CRVS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Corvus Pharmaceuticals, Inc. is in the Healthcare sector.